ANI Pharmaceuticals, Inc. has delivered on an agreement with Oakrum Pharma, a biopharmaceutical company specializing in affordable drug therapies, to launch the first US generic version of Recordati’s Cystadane (betaine anhydrous) powder for oral solution, with 180 days of Competitive Generic Therapy exclusivity.
ANI and Oakrum have begun the shipping of Cystadane generic since early February 2022.




